CHP
KITE

Cable Hill Partners’s Kite Pharma, Inc. KITE Stock Holding History

Cable Hill Partners’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-73
Closed -$13K – 1074
2017
Q3 		$13K Buy
+73
New +$10.2K 0.01% 520

Cable Hill Partners's KITE Position: Q4 2017 in Review

Cable Hill Partners sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 73 shares — an estimated $13K sold.

Cable Hill Partners first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $13K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Cable Hill Partners reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Cable Hill Partners sold 73 Kite Pharma, Inc. shares in Q4 2017, an estimated $13K.
  • Cable Hill Partners first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
  • Cable Hill Partners's Kite Pharma, Inc. position peaked at $13K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Cable Hill Partners's 13F filing for Q4 2017, filed 22 Feb 2018.